Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Παρόμοια τεκμήρια

• FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
  ανά: Griffiths, G, κ.ά.
  Έκδοση: (2009)
• Issues in data monitoring and interim analysis of trials.
  ανά: Grant, A, κ.ά.
  Έκδοση: (2005)
• CANparent trial evaluation: second interim report
  ανά: Cullen, M, κ.ά.
  Έκδοση: (2014)
• CANparent trial evaluation: First interim report
  ανά: Cullen, M, κ.ά.
  Έκδοση: (2013)
• Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial
  ανά: Masahide Oki, κ.ά.
  Έκδοση: (2024-12-01)